Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Case Report


Article page

172-173


Authors Details

Anjana Devi Rudra Warrier*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 476

PDF Downloaded: 211


Zoledronic acid induced uveitis in multiple myeloma - A case report


Case Report

Author Details : Anjana Devi Rudra Warrier*

Volume : 8, Issue : 1, Year : 2022

Article Page : 172-173

https://doi.org/10.18231/j.ijceo.2022.033



Suggest article by email

Get Permission

Abstract

This is the case report of a 67-year-old lady who was diagnosed to have Multiple Myeloma and was given injection Zoledronic acid and developed Anterior Uveitis in both eyes. Uveitis was cured completely with topical steroids and she did not have any recurrence, even though injection Zoledronic acid was continued for one year. This shows that even if the patient develops ocular inflammation with the first dose, the treatment can be continued with monitoring after discussing the risks and benefits with the patient, since the patient can develop tolerance with each infusion.
 

Keywords: Zoledronic acid, Multiple myeloma, Uveitis.


How to cite : Warrier A D R, Zoledronic acid induced uveitis in multiple myeloma - A case report. Indian J Clin Exp Ophthalmol 2022;8(1):172-173

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.